Spinraza in the United States
Spinraza (also known as Nusinersen) was approved by the FDA in the USA on 23rd December 2016 as a treatment for SMA. Although the approval process in Europe and the UK is separate to the USA, you can read more about what’s happening over there through the links below.
Cure SMA is a leading charity in the United States supporting families affected by spinal muscular atrophy.
Sprinraza.com is a website set up by Biogen to inform US caregivers about Spinraza.